Leigh B. Waddell
Westmead, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone.
Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone.
Journal: Annals of clinical and translational neurology
Published: February 02, 2024
Congenital Titinopathy: Comprehensive Characterization of the Most Severe End of the Disease Spectrum.
Journal: Annals of neurology
Published: August 24, 2023
Connective tissue presentation in two families expands the phenotypic spectrum of PYROXD1 disorders.
Connective tissue presentation in two families expands the phenotypic spectrum of PYROXD1 disorders.
Journal: Human molecular genetics
Published: January 08, 2023
Compound heterozygous splicing variants expand the genotypic spectrum of EMC1-related disorders.
Journal: Clinical genetics
Published: August 31, 2022
A genetic basis is identified in 74% cases of paediatric hyperCKaemia without weakness presenting to a tertiary paediatric neuromuscular centre.
Journal: Neuromuscular disorders : NMD
Published: March 03, 2022
Biallelic and monoallelic variants in PLXNA1 are implicated in a novel neurodevelopmental disorder with variable cerebral and eye anomalies.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: September 02, 2020
Heterozygous CAPN3 missense variants causing autosomal-dominant calpainopathy in seven unrelated families.
Journal: Neuropathology and applied neurobiology
Published: May 04, 2020
WGS and RNA Studies Diagnose Noncoding DMD Variants in Males With High Creatine Kinase.
Journal: Neurology. Genetics
Published: May 01, 2020
Pathogenic deep intronic MTM1 variant activates a pseudo-exon encoding a nonsense codon resulting in severe X-linked myotubular myopathy.
Journal: European journal of human genetics : EJHG
Published: March 25, 2020
MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement.
Journal: Acta neuropathologica
Published: May 06, 2019
Last Updated: 09/26/2026